Considerations in the use of hydroxypropyl-β-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 50, Issue 2, 2000, Pages 237-244

  Bary, Andrew R ^a   Tucker, Ian G ^a   Davies, Nigel M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Complexation; Corneal permeability; Hydrocortisone; Hydroxypropyl cyclodextrin; Ocular bioavailability; Polymers

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; EYE DROPS; HYDROCORTISONE; POLYMER;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG BIOAVAILABILITY; DRUG FORMULATION; NONHUMAN; VISCOSITY;

ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; EYE; HYDROCORTISONE; OPHTHALMIC SOLUTIONS; PERMEABILITY; POLYVINYLS; RABBITS; SWINE;

EID: 0033839819     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(00)00108-9     Document Type: Article

References (40)

1. H.M. Leibowitz, A. Kupferman, Bioavailability and therapeutic effectiveness of topically administered corticosteroids, Trans. Am. Acad. Ophthalmol. Otol. 79 (1975) 78-88.
2. D.G. Musson, A.M. Bidgood, O. Olejnik, An in vitro comparison of the permeability of prednisolone, prednisolone sodium phosphate, and prednisolone acetate across the NZW rabbit cornea, J. Ocul. Pharmacol. 8 (2) (1992) 139-150.
3. J.W. Sieg, J.R. Robinson, Vehicle effects on ocular drug bioavailability I: evaluation of fluorometholone, J. Pharm. Sci. 64 (1975) 931-936.
4. R.D. Schoenwald, P. Stewart, Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits, J. Pharm. Sci. 69 (4) (1980) 391-394.
5. C.N. McGhee, D.G. Watson, J.M. Midgley, M.J. Noble, G.N. Dutton, A.I. Fern, Penetration of synthetic corticosteroids into human aqueous humour, Eye 4 (3) (1990) 526-530.
6. M. Diestelhorst, K.A. Kwon, R. Süverkrüp, Dose uniformity of ophthalmic suspensions, J. Cat. Refr. Surg. 28 (5) (1998) 672-677.
7. A. Usayapant, A.M. Karara, M.M. Narurkar, Effect of 2-hydroxypropyl-β-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate, Pharm. Res. 8 (1991) 1495-1499.
8. T. Loftsson, H. Frioriksdóttir, S. Thórisdóttir, E. Stefánsson, Effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations, Int. J. Pharm. 104 (1994) 181-184.
9. J.K. Kristinsson, H. Frióriksdóttir, S. Thórisdóttir, A.M. Siguróardóttir, E. Stefánsson, T. Loftsson, Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans, Invest. Ophthalmol. Vis. Sci. 37 (6) (1996) 1199-1203.
10. N.M. Davies, G. Wang, I.G. Tucker, Evaluation of a hydrocortisone/hydroxypropyl-β-cyclodextrin solution for ocular drug delivery, Int. J. Pharm. 156 (1997) 201-209.
11. J. Szejtli, Cyclodextrin Technology, 1st Edition, Kluwer, Dordrecht, 1988.
12. A. Hersey, B. Robinson, H. Kelly, Mechanism of inclusion-compound formation for binding of organic dyes, ions and surfactants to α-cyclodextrin studied by kinetic methods based on competition experiments, J. Chem. Soc. Faraday Trans. 82 (1986) 1271-1287.
13. K.M. Uekama, Y. Otagiri, Cyclodextrins in drug carrier systems, CRC Crit. Rev. Ther. Drug Carrier Sys. 3(1) (1987) 1-40.
14. M. Tanaka, Y. Iwata, Y. Kouzuki, K. Taniguchi, H. Matsuda, H. Arima, S. Tsuchiya, Effect of 2-hydroxypropyl-β-cyclodextrin on percutaneous absorption of methylparaben, J. Pharm. Pharmacol. 47 (1995) 897-900.
15. B. Siefert, U. Pleyer, M. Muller, C. Hartmann, S. Keipert, Influence of cyclodextrins on the in vitro corneal permeability and in vivo ocular distribution of thalidomide, J. Ocul. Pharmacol. 15 (5) (1999) 429-438.
16. P. Suhonen, T. Jarvinen, K. Lehmussaari, T. Reunamaki, A. Urtti, Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop, Pharm. Res. 12 (1995) 529-533.
17. P. Jarho, K. Jarvinen, A. Urtti, V.J. Stella, T. Jarvinen, Modified β-cyclodextrin (SBE7-β-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits, J. Pharm. Pharmacol. 48 (1996) 263-269.
18. K. Masuda, M. Tohno, Y. Konishi, H. Kojima, M. Matsumura, Ocular penetration of flurbiprofen, an anti-inflammatory drug, in rabbits after topical instillation, Atarashi Ganka 2 (3) (1985) 441-443.
19. J. Yuan, Estimation of variance for AUC in animal studies, J. Pharm. Sci. 82 (7) (1993) 761-763.
20. O. Camber, An in vitro model for determination of drug permeability through the cornea, Acta Pharm. Suec. 22 (1985) 335-342.
21. O. Camber, C. Rehbinder, T. Nikkila, P. Edman, Morphology of the pig cornea in normal conditions and after incubation in a perfusion apparatus, Acta Vet. Scand. 28 (2) (1987) 127-134.
22. J. Crank, The Mathematics of Diffusion, Oxford University Press, Oxford, 1956.
23. H. Okamoto, H. Komatsu, M. Hashida, H. Sezaki, Effects of β-cyclodextrin and di-O-methyl-β-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulfanilic acid, Int. J. Pharm. 30 (1986) 35-45.
24. T. Loftsson, H. Frióriksdóttir, A.M. Siguróardóttir, H. Ueda, Effect of water-soluble polymers on drug-cyclodextrin complexation, Int. J. Pharm. 110 (1994) 169-177.
25. T. Loftsson, T.K. Guómundsdóttir, H. Frióriksdóttir, The influence of water-soluble polymers and pH on hydroxypropyl-β-cyclodextrin complexation of drugs, Drug Dev. Ind. Pharm. 22 (1996) 401-405.
26. A.M. Siguróardóttir, T. Loftsson, The effect of polyvinylpyrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin, Int. J. Pharm. 126 (1995) 73-78.
27. R. Gurny, H. Ibrahim, A. Aebi, P. Buri, C.G. Wilson, N. Washington, P. Edman, O. Camber, Design and evaluation of controlled release systems for the eye, J. Control. Release 6 (1987) 367.
28. N.M. Davies, S.J. Farr, J. Hadgraft, I.W. Kellaway, Evaluation of mucoadhesive polymers in ocular drug delivery, Part 1. Viscous solutions, Pharm. Res. 8 (1991) 1039-1043.
29. O. Camber, P. Edman, R. Gurny, Influence of sodium hyaluronate on the miotic effect of pilocarpine in rabbits, Curr. Eye Res. 6 (1987) 779-784.
30. O. Camber, P. Edman, Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine, Curr. Eye Res. 8 (1989) 563-567.
31. M.F. Saettone, B. Giannaccini, B. Guiducci, P. Savigni, Semisolid ophthalmic vehicles, III. An evaluation of four organic hydrogels containing pilocarpine, Int. J. Pharm. 31 (1986) 261-270.
32. M.F. Saettone, P. Chetoni, M. Torracca, S. Burgalassi, B. Giannaccini, Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid, Int. J. Pharm. 51 (1989) 203-212.
33. M.F. Saettone, B. Giannaccini, P. Chetoni, M.T. Torracca, D. Monti, Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine, Int. J. Pharm. 72 (1991) 131-139.
34. S.F. Bernatchez, C. Tabatabay, R. Gurny, Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin, Graef. Arch. Clin. Exp. Ophthalmol. 231 (1993) 157-161.
35. M. Nomura, M.A. Kubota, R. Kawamori, Y. Yamasaki, T. Kamada, H. Abe, Effect of addition of hyaluronic acid to highly concentrated insulin on absorption from the conjunctiva in conscious diabetic dogs, J. Pharm. Pharmacol. 46 (1994) 768-770.
36. D.B. Jack, Handbook of Clinical Pharmacokinetic Data, Macmillan, London, UK, 1992.
37. G.M. Grass, J.R. Robinson, Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability, J. Pharm. Sci. 73 (1984) 1021-1027.
38. B. Siefert, S. Keipert, Influence of α-cyclodextrin and hydroxyalkylated β-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions, J. Pharm. Sci. 86 (1997) 716-720.
39. T. Jansen, B. Xhonneux, J. Mesens, M. Borgers, β-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium, Lens Eye Tox. Res. 7 (1990) 459-468.
40. K.A. Freedman, J.W. Klein, C.E. Crosson, β-cyclodextrins enhance bioavailability of pilocarpine, Curr. Eye Res. 12 (1993) 641-647.